VPEG is pleased to announce its investment into Healion Bio via a convertible debt instrument. Healion Bio was established by Dr. Sina Bavari and Simon Newman to develop cures and preventative medicines for diseases caused by a variety of biologic pathogens for which there are few or no good treatment options.
— VPEG Executes Investment in Healion Bio